flurbiprofen and (2R,4R)-N-(1H-benzimidazol-2-ylmethyl)-2-[[4-(hydroxymethyl)phenyl]methoxy]-4-[4-(trifluoromethyl)phenyl]-3,4-dihydro-2H-pyran-6-carboxamide

flurbiprofen has been researched along with (2R,4R)-N-(1H-benzimidazol-2-ylmethyl)-2-[[4-(hydroxymethyl)phenyl]methoxy]-4-[4-(trifluoromethyl)phenyl]-3,4-dihydro-2H-pyran-6-carboxamide in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abagyan, R; Cottam, HB; Kaler, G; Saldanha, SA; Taylor, SS1

Other Studies

1 other study(ies) available for flurbiprofen and (2R,4R)-N-(1H-benzimidazol-2-ylmethyl)-2-[[4-(hydroxymethyl)phenyl]methoxy]-4-[4-(trifluoromethyl)phenyl]-3,4-dihydro-2H-pyran-6-carboxamide

ArticleYear
Assay principle for modulators of protein-protein interactions and its application to non-ATP-competitive ligands targeting protein kinase A.
    Analytical chemistry, 2006, Dec-15, Volume: 78, Issue:24

    Topics: Adenosine Triphosphate; Amino Acid Sequence; Binding, Competitive; Biological Assay; Cyclic AMP-Dependent Protein Kinases; Fluorescence Polarization; Ligands; Molecular Sequence Data; Protein Binding; Substrate Specificity

2006